Peter Olinga Selected Research

Peter Olinga Research Topics

Disease

35	Fibrosis (Cirrhosis) 01/2022 - 11/2006
11	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 08/2004
9	Inflammation (Inflammations) 01/2022 - 10/2015
4	Crohn Disease (Crohn's Disease) 01/2021 - 10/2015
3	Necrosis 01/2019 - 08/2015
3	Cholestasis 03/2017 - 11/2004
3	Chronic Renal Insufficiency 01/2017 - 01/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021 - 02/2019
2	Atrophy 01/2021 - 01/2021
2	Reperfusion Injury 01/2021 - 11/2005
2	Neoplasms (Cancer) 01/2018 - 04/2016
2	Disease Progression 01/2017 - 01/2015
1	Acute-On-Chronic Liver Failure 01/2022
1	Fatty Liver 11/2021
1	Alcoholic Fatty Liver 11/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2021
1	Insulin Resistance 01/2021
1	Ischemia 01/2021
1	Biliary Atresia 01/2020
1	Cicatrix (Scar) 01/2020
1	Pathologic Constriction (Stenosis) 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Osteoarthritis 12/2019
1	Ureteral Obstruction 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 07/2021 - 01/2014
7	CollagenIBA 01/2021 - 01/2014
7	Pharmaceutical PreparationsIBA 05/2020 - 02/2005
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2015
6	Adenosine Triphosphate (ATP)IBA 03/2017 - 02/2005
5	CytokinesIBA 01/2022 - 02/2005
5	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 10/2015
5	Messenger RNA (mRNA)IBA 01/2020 - 11/2006
4	Collagen Type I (Type I Collagen)IBA 07/2021 - 01/2017
3	Insulin (Novolin)FDA Link 11/2021 - 02/2019
3	Extracellular Matrix ProteinsIBA 01/2021 - 01/2015
3	LY2109761IBA 11/2020 - 01/2017
3	EnzymesIBA 01/2020 - 03/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2015
2	Palmitic Acid (Hexadecanoic Acid)IBA 11/2021 - 02/2019
2	FructoseIBA 11/2021 - 02/2019
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2020
2	VimentinIBA 01/2021 - 10/2015
2	Phosphotransferases (Kinase)IBA 01/2020 - 09/2017
2	LY-2157299IBA 01/2020 - 09/2017
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 09/2016
2	Interleukin-6 (Interleukin 6)IBA 11/2017 - 01/2017
1	Interleukin-13IBA 01/2022
1	InterleukinsIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 11/2021
1	Butyrates (Butyrate)IBA 11/2021
1	Oleic Acid (Oleate)IBA 11/2021
1	LipidsIBA 11/2021
1	Fibronectins (Fibronectin)IBA 07/2021
1	linrodostatIBA 07/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 07/2021
1	Polystyrenes (Polystyrene)IBA 01/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2021
1	Muscle Proteins (Muscle Protein)IBA 01/2021
1	titanium dioxide (Titania)FDA Link 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021
1	Sunitinib (Sutent)FDA Link 11/2020
1	Plasminogen Activator Inhibitor 1IBA 11/2020
1	pirfenidoneIBA 11/2020
1	OsteoprotegerinIBA 05/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	nintedanibIBA 01/2020
1	2- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acidIBA 01/2020
1	Adalimumab (Humira)FDA Link 01/2020
1	Infliximab (Remicade)FDA Link 01/2020
1	Cathepsin KIBA 01/2020
1	OsteopontinIBA 01/2020
1	CateninsIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Complement C3 (C3 Complement)IBA 01/2020
1	Complement C4 (Complement Component 4)IBA 01/2020
1	Collagen ReceptorsIBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2020
1	IntegrinsIBA 12/2019
1	HMGB1 Protein (HMG1)IBA 12/2019
1	Oxygen (Dioxygen)IBA 11/2019
1	AntioxidantsIBA 11/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 11/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	butaprostIBA 01/2019
1	Dinoprostone (PGE2)FDA Link 01/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Smad2 ProteinIBA 01/2018

Therapy/Procedure

10	Therapeutics 03/2021 - 03/2006
2	Aftercare (After-Treatment) 11/2020 - 09/2017
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2017 - 10/2015
1	Liver Transplantation 01/2022
1	Transplantation 01/2021